|
 |
AcularThis page contains recent news articles, when available, and an overview of Acular but does not offer medical advice. You should contact your physician with regard to any health issues or concerns....gentleman bon vivant Alan Cumming presented his one-man reminisce-a-thon (not to mention belt-it-out-acular) at the Geffen Playhouse a few months back. ... NBC Los Angeles Looking for lights? Check these out - Dec 16, 2009 Holiday Craft-acular: 10 am to 1 pm Saturday, Lacey Timberland Regional Library, 500 College St. SE, Lacey. Children can stop by the library and make a ... The Olympian Idaho and Bowling Green hope to end season on high - Dec 29, 2009 ...but the bigger key against Bowling Green will be Idaho's tailback trio: De'Maundray Woolridge, Princeton McCarty and Deonte Jackson. acular season, ... The Spread Sun Pharmaceutical's US subsidiary receives USFDA nod for Cetirizine ... - 14 Nov 2009 Sun Pharmaceutical, on Nov 10, won authorization from Food and Drug Administration (FDA) for ANDA of its arm for generic Acular, ketorolac tromethamine ... Stock Watch Caraco Pharmaceutical Laboratories, Ltd. Markets Generic Acular(R) Ophthalmic ... - Nov 6, 2009 DETROIT, Nov. 6 /PRNewswire-FirstCall/ -- Caraco Pharmaceutical Laboratories, Ltd. (NYSE Amex: CPD) has launched ketorolac tromethamine ophthalmic solution, ... CNNMoney.com (press release) Akorn takes 3Q loss on weak vaccine revenue - Nov 10, 2009 Akorn said it is launched generic versions of Acular, a treatment for seasonal conjunctivitis, and hydralazine hydrochloride, which is used against high ... CNBC Akorn Inc. swings to a loss - Nov 11, 2009 Akorn launched two generic drugs: Ketorolac Tromethamine Ophthalmic, the generic form of Acular, used to relieve seasonal allergy eye-itching, ... Medill Reports: Chicago Generic Name: Ketorolac, ketorolac tromethamine - Nov 11, 2009 Acular (generic name: Ketorolac tromethamine) belongs to the class of medications called nonsteroidal anti-inflammatory drugs. Acular is used to relieve the ... Pattaya Daily News xtremepicks.com: www.Xtremepicks.Com: Xtremepicks Alerts November 6, 2009 ... - Nov 6, 2009 In a press release out on November 6, Caraco Pharmaceutical Laboratories, Ltd. Markets Generic Acular(R) Ophthalmic Solution DETROIT, Nov 06, 2009 -- Caraco ... Trading Markets (press release) Caraco Pharma Gets OK For Eye Drug - Nov 8, 2009 This strength of ketorolac is therapeutically equivalent to Acular Ophthalmic Solution, 0.5 percent, from Allergan Inc. Ketorolac tromethamine ophthalmic ... WWJ Caraco releases seasonal allergic conjunctivitis treatment - Nov 9, 2009 ...to seasonal allergic conjunctivitis. The drug is a generic version of Allergan's Acular, which has sales of about $40 million a year, according to Caraco. Drug Store News (blog) Investors snap up IMS Health for $5.2B; Amgen cancer med fails to boost ... - Nov 6, 2009 Report > Sun Pharmaceutical secured FDA approval for its copycat version of Allergan's Acular, used to treat ocular itching. ... FiercePharma Ketorolac Tromethamine Injection Recall Issued Due to Contamination - Oct 22, 2009 Ketorolac Tromethamine is the generic version of Toradol and Acular. It is a prescription non-steroidal anti-inflammatory drug (NSAID) also used as a pain ... AboutLawsuits.com News and FDA Updates for Phase Forward (NASDAQ:PFWD), BioSpecifics (Nasdaq ... - Nov 7, 2009 ...(FDA) for Sun Pharma's Abbreviated New Drug Application (ANDA) for generic Acular® ophthalmic solution on the first day following patent expiration. American Chronicle Allergan Q3 2009 Earnings Call Transcript - Oct 29, 2009 ACUVAIL has proceed to the real product improvements relative to ACULAR with the convenience of two versus four times a day dosing with additional comfort ... Seeking Alpha (blog) Allergan Claims Victory in Patent Suit Over Generics - Nov 7, 2009 Earlier in the decade, Allergan prevailed in a lawsuit that alleged Apotex and its Novex Pharma unit infringed on a patent for Acular, which treats ... Orange County Business Journal BiomedReports: News and FDA Updates for Phase Forward (NASDAQ:PFWD ... - Nov 9, 2009 ...(FDA) for Sun Pharma's Abbreviated New Drug Application (ANDA) for generic Acular ophthalmic solution on the first day following patent expiration. ... Trading Markets (press release) |
|
Health Home | Conditions | Cancer | Medications | Surgery | Vaccines The Cancer News Network
COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy |
